Standard Biotools Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +296.8% | +11.3% | +3.7% | -10.9% | +7.1% | -10.2% | +1.7% | -7.2% | +1.0% | +11.1% | -89.8% | |
| – | -19.6% | -17.7% | -34.4% | +21.2% | +3.4% | +26.8% | +11.4% | -7.6% | -11.8% | +141.8% | -6.7% | |
| – | – | – | – | – | +104.7% | -34.3% | +10.3% | +66.5% | – | – | – | |
| – | – | – | +93.7% | -126.9% | – | – | -845.9% | – | – | -775.9% | – | |
| – | +43.9% | -52.5% | -68.1% | -77.0% | +580.4% | +402.4% | +4.3% | -71.2% | -26.0% | +195.1% | -0.6% | |
| – | – | +75.2% | -60.8% | -73.3% | -932.8% | – | -129.9% | +637.7% | – | +1,694.6% | -93.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -26.5% | – | +109.1% | -101.0% | -27.0% | +290.6% | -56.8% | +599.5% | +656.4% | – | |
| – | – | – | – | – | +0.0% | +414.7% | +0.0% | -65.6% | -137.1% | +2,933.7% | -100.0% | |
| – | -97.4% | -98.6% | +38,053.9% | +98.8% | -95.2% | +647.6% | -23.5% | +1,345.9% | -103.0% | +1,407.1% | – | |
| – | – | – | +288.2% | +62.3% | -291.9% | – | -187.5% | – | -156.4% | – | -141.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.